最新ニュース Synergy CHC (NASDAQ:SNYR) 株価情報

Synergy CHC

Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.

Synergy CHC Corp

Cisco Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) will release its third-quarter financial results after the closing <a href="https://www.benzinga.com/quote/CSCO/earnings">bell on Wednesday, May 14.</a>
Analysts expect the San Jose, California-based company to report quarterly earnings at 92 cents per share, up from 88 cents per share in the year-ago period. Cisco projects quarterly revenue of $14.06 billion, compared to $12.7 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 28, Evercore ISI Group analyst Amit Daryanani maintained Cisco with an Outperform rating and lowered the price target from $75 to $67.
The recent buzz around Cisco may have investors eyeing potential gains from the company's dividends. Currently, Cisco offers an annual dividend yield of 2.66%. That&#8217;s a quarterly dividend of 41 cents per share ($1.64 a year).
To figure out how to earn $500 monthly from Cisco, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by Cisco's $1.64 dividend: $6,000 / $1.64 = 3,659 shares.
So, an investor would need to own approximately $225,651 worth of Cisco, or 3,659 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $1.64 = 732 shares, or $45,142 to generate a monthly dividend income of $100.
Investors should note that dividend yields can change on a rolling basis. The dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
CSCO Price Action: Shares of Cisco gained by 3.2% to close at $61.67 on Monday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/05/45347009/top-2-tech-stocks-that-may-crash-in-q2">Top 2 Tech Stocks That May Crash In Q2</a></li>
</ul>
Image: Shutterstock

Earnings

Long Ideas

News

Markets

Trading Ideas

CSCO

How To Earn $500 A Month From Cisco Stock Ahead Of Q3 Earnings

Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) reported quarterly losses of $(3.37) per share. This is a 99.15 percent increase over losses of $(394.76) per share from the same period last year.

BJDX

Bluejay Diagnostics Q1 EPS $(3.37) Up From $(394.76) YoY

Investcorp Credit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICMB#NASDAQ">ICMB</a>) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.11 by 54.55 percent. This is a 64.29 percent decrease over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $4.37 million which missed the analyst consensus estimate of $5.27 million by 17.13 percent. This is a 34.00 percent decrease over sales of $6.62 million the same period last year.

Earnings Misses

ICMB

Investcorp Credit Q3 EPS $0.05 Misses $0.11 Estimate, Sales $4.37M Miss $5.27M Estimate

Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.35) by 28.57 percent. This is a 36.36 percent decrease over losses of $(0.33) per share from the same period last year.

BLTE

Belite Bio Q1 EPS $(0.45) Misses $(0.35) Estimate

Tvardi Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVRD#NASDAQ">TVRD</a>) reported quarterly losses of $(3.22) per share which missed the analyst consensus estimate of $(0.31) by 938.71 percent. This is a 84.09 percent increase over losses of $(20.24) per share from the same period last year. The company reported $2.57 million in sales this quarter. This is a 20.33 percent increase over sales of $2.13 million the same period last year.

TVRD

Tvardi Therapeutics Q1 EPS $(3.22) Misses $(0.31) Estimate, Sales $2.57M Up From $2.13M YoY

Reported Earlier, GreenPower Motor Announces $2M Term Loan Offering To Support Production And Working Capital

Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) reported quarterly losses of $(2.75) per share. This is a 49.45 percent increase over losses of $(5.44) per share from the same period last year.

PTIX

Protagenic Therapeutics Q1 EPS $(2.75) Up From $(5.44) YoY

Hall Of Fame Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFV#NASDAQ">HOFV</a>) reported quarterly losses of $(2.30) per share which missed the analyst consensus estimate of $(2.23) by 3.14 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.94 million which missed the analyst consensus estimate of $3.75 million by 21.47 percent. This is a 29.73 percent decrease over sales of $4.19 million the same period last year.

HOFV

Hall Of Fame Resort Q1 EPS $(2.30) Misses $(2.23) Estimate, Sales $2.94M Miss $3.75M Estimate

Korea's sixth-generation supercomputer, KISTI-6, will be 100% direct liquid-cooled to enable AI and HPC simulation for researchers across academia and industry

Reported Earlier, Hewlett Packard Enterprise Selected By KISTI To Deliver South Korea's Sixth-Generation, AI-Powered Supercomputer

Uber estimates that the net proceeds from the offering will be approximately $978.9 million (or $1,125.9 million if the initial purchaser exercises its option to purchase additional notes in full), after deducting the initial purchaser's discount and estimated offering expenses payable by Uber. Uber intends to use the net proceeds from the offering for general corporate purposes, which may include strategic investments, although Uber has not designated any specific uses at this time.

UBER

Reported Earlier, Uber Prices $1B In 0.0% Exchangeable Senior Notes Due 2028, Exchangeable Into Aurora Innovation Stock

Kezar Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZR#NASDAQ">KZR</a>) reported quarterly losses of $(2.27) per share which beat the analyst consensus estimate of $(2.61) by 13.03 percent. This is a 24.33 percent increase over losses of $(3.00) per share from the same period last year.

Earnings Beats

Kezar Life Sciences Q1 EPS $(2.27) Beats $(2.61) Estimate

Avalon Globocare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALBT#NASDAQ">ALBT</a>) reported quarterly losses of $(1.43) per share. This is a 20.56 percent increase over losses of $(1.80) per share from the same period last year. The company reported $349.80 thousand in sales this quarter. This is a 11.19 percent increase over sales of $314.59 thousand the same period last year.

ALBT

Avalon Globocare Q1 EPS $(1.43) Up From $(1.80) YoY, Sales $349.80K Up From $314.59K YoY

Pluri (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUR#NASDAQ">PLUR</a>) reported quarterly losses of $(0.94) per share. This is a 6.93 percent increase over losses of $(1.01) per share from the same period last year. The company reported $427.00 thousand in sales this quarter. This is a 501.41 percent increase over sales of $71.00 thousand the same period last year.

PLUR

Pluri Q3 EPS $(0.94) Up From $(1.01) YoY, Sales $427.00K Up From $71.00K YoY

Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) announced on Tuesday it will eliminate approximately 6,000 positions globally, representing 3% of its workforce, as the tech giant seeks to streamline operations and reduce middle management layers.
What Happened: &#8220;We continue to implement organisational changes necessary to best position the company for success in a dynamic marketplace,&#8221; Microsoft said in a statement, <a href="https://www.ft.com/content/f453e330-1e56-4b45-9889-382098025415">reported</a> the Financial Times.
The Redmond, Washington-based company joins other tech giants, including Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), in <a href="https://www.benzinga.com/25/05/45250949/tech-layoffs-get-the-headlines-but-its-uncle-sam-doge-whos-bleeding-workers-in-2025">workforce reductions while simultaneously increasing investments</a> in artificial intelligence technologies.
This latest round follows performance-related cuts affecting about 2,000 Microsoft employees earlier this year. The company previously eliminated approximately 2,500 positions from its Xbox division after acquiring Activision Blizzard, along with 1,000 roles across its HoloLens and Azure cloud computing units in the same period.
See Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45390422/trump-unveils-historic-and-transformative-600-billion-saudi-deal-predicts-markets-will-go-a-lot-higher">Trump Unveils &#8216;Historic And Transformative&#8217; $600 Billion Saudi Deal, Predicts Markets Will &#8216;Go A Lot Higher&#8217;</a>
Why It Matters: Microsoft&#8217;s CFO Amy Hood recently told investors the company was focused on &#8220;building high-performing teams and increasing our agility by reducing layers with fewer managers.&#8221; CEO Satya Nadella had earlier indicated that between 20-30% of the company&#8217;s code was <a href="https://www.benzinga.com/tech/25/04/45093643/ai-is-reshaping-coding-at-microsoft-says-nadella-30-of-code-now-ai-generated">now being written using AI tools</a>.
The layoffs come despite Microsoft&#8217;s <a href="https://www.benzinga.com/quote/MSFT/earnings">strong financial performance</a>. The company reported better-than-expected earnings for the quarter ending March and has outperformed its peers since the beginning of 2025, recently reclaiming its position as the world&#8217;s most valuable company.
The cuts affect international offices and wholly-owned subsidiaries like LinkedIn, reflecting a broader trend of workforce rebalancing across the technology sector.
Price Action: Microsoft Corp.&#8217;s stock closed at $449.14 on Tuesday, down 0.03% for the day. In after-hours trading, the stock dipped further to $448.27, a decline of 0.19%. Year to date, Microsoft&#8217;s stock has gained 7.30%. 
Microsoft is experiencing modest growth but continues to benefit from strong momentum. However, the stock scores lower on quality and valuation metrics, according to Benzinga Edge Stock Rankings. MSFT maintains a positive trend across both short- and long-term indicators. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Sign up to learn more.</a>
Photo Courtesy: Tada Images on Shutterstock.com
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45396297/cathie-wood-dumps-palantir-as-stock-touches-peak-prices-bails-on-soaring-flying-taxi-maker-archer-aviation">Cathie Wood Dumps Palantir As Stock Touches Peak Prices, Bails On Soaring Flying-Taxi Maker Archer Aviation</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

AMZN

MSFT

Microsoft To Cut 6,000 Jobs Globally Amid AI-Driven Shift, Says Changes Necessary To 'Best Position The Company For Success'

Pharvaris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHVS#NASDAQ">PHVS</a>) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.82) by 8.54 percent. This is a 58.93 percent decrease over losses of $(0.56) per share from the same period last year.

PHVS

Pharvaris Q1 EPS $(0.89) Misses $(0.82) Estimate

Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.79) by 12.66 percent. This is a 258.93 percent decrease over earnings of $0.56 per share from the same period last year.

SONN

Sonnet BioTherapeutics Q2 EPS $(0.89) Misses $(0.79) Estimate

IGM Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGMS#NASDAQ">IGMS</a>) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.48) by 4.17 percent. This is a 39.76 percent increase over losses of $(0.83) per share from the same period last year. The company reported quarterly sales of $499.00 thousand which missed the analyst consensus estimate of $3.10 million by 83.91 percent. This is a 0.40 percent increase over sales of $497.00 thousand the same period last year.

IGMS

IGM Biosciences Q1 EPS $(0.50) Misses $(0.48) Estimate, Sales $499.00K Miss $3.10M Estimate

Nyxoah (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYXH#NASDAQ">NYXH</a>) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.50) by 25.8 percent. This is a 39.78 percent decrease over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $1.10 million which missed the analyst consensus estimate of $1.64 million by 32.70 percent. This is a 16.76 percent decrease over sales of $1.33 million the same period last year.

NYXH

Nyxoah Q1 EPS $(0.63) Misses $(0.50) Estimate, Sales $1.10M Miss $1.64M Estimate

Publicly-listed holding company GD Culture Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDC#NASDAQ">GDC</a>) announced its intentions to raise up to $300 million to build a cryptocurrency reserve made up of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Official Trump (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>) on Monday.
What Happened: The Nasdaq-listed firm plans to use the&nbsp;proceeds from a stock sale&nbsp;to an &#8220;accredited&#8221;&nbsp;entity in the British Virgin&nbsp;Islands to finance this investment, according to a press release.
GDC said it wanted to improve its balance sheet with &#8220;high-performance, scalable digital assets,&#8221; as part of a broader pivot toward decentralized finance.
The company conducts business mainly through its wholly owned U.S. subsidiary AI Catalysis Corp. and China-based Shanghai Xianzhui Technology Co, Ltd.
GDC, which runs an e-commerce business on the Chinese-owned video-sharing app TikTok, reported no revenue last year and has a small team of just eight employees, <a href="https://www.nytimes.com/2025/05/13/us/politics/trump-crypto-purchase.html">reported </a>The New York Times, citing public filings.
See Also:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/05/45351445/xrp-skyrockets-10-what-is-going-on" target="_blank" rel="noreferrer noopener">XRP Skyrockets 10%: What Is Going On?</a>
Why It Matters: This move by GDC comes days after&nbsp;Freight Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>)&nbsp;<a href="https://www.benzinga.com/25/05/45159094/trumps-official-memecoin-adopted-as-reserve-asset-by-freight-technologies-to-advocate-for-fair-balanced-us-mexico-trade">became the first public company to adopt</a> President Donald Trump&#8217;s meme coin as a treasury reserve asset. 
The cross-border logistics company said the decision was an &#8220;effective&#8221; way to advocate for fair and free trade between Mexico and the U.S.
The meme coin has sparked political outrage, with Democratic lawmakers <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45027557/trumps-memecoin-dinner-event-sparks-impeachment-call-from-democratic-senator-says-potus-is-selling-access-to-those-who-enrich-him">accusing Trump of corruption</a> for selling access to himself in exchange for payments made with his meme coin. Trump has <a href="https://www.benzinga.com/25/05/45187462/trump-denies-personal-profit-from-memecoin-venture-i-havent-even-look">refuted claims</a> that he is financially benefiting from the coin.
Price Action: At the time of writing, TRUMP was exchanging hands at $13.56, up 7.53% in the last 24 hours, according to&nbsp;<a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Shares of GDC were up 3.27% in after-hours trading after closing 2.73% lower at $2.140 during Tuesday's regular session. The stock was up 13.23% year-to-date.
GDC scored high on the momentum metric as of this writing. If you want to fill your portfolio with similar high-momentum stocks, visit <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a> for more details.
Photo Courtesy: Bori Slim On Shutterstock.com 
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="505" height="187" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14005031/Screenshot-2025-05-14-102018.png" alt="" class="wp-image-914391" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14005031/Screenshot-2025-05-14-102018.png 505w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14005031/Screenshot-2025-05-14-102018-300x111.png 300w" sizes="(max-width: 505px) 100vw, 505px" /></figure>
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://benzinga.com/markets/cryptocurrency/25/05/45335756/cathie-wood-stands-firm-on-bold-700000-bitcoin-prediction-for-investors-says-bull-case-in-the-1-5-million-range" target="_blank" rel="noreferrer noopener">Cathie Wood Stands Firm on Bold $700,000 Bitcoin Prediction for Investors, Says ‘Bull Case in the $1.5 Million Range&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Politics

$BTC

$TRUMP

FRGT

Trump Memecoin Adopted By China-Linked Nasdaq Company As Treasury Reserve Asset

Swiss athletic footwear company On Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) saw its stock jump 12% following stellar first-quarter of 2025 results that handily beat analyst expectations, demonstrating the strength of its premium positioning strategy.
What Happened: The former tennis player Roger Federer-backed company reported first-quarter net sales of CHF726.6 million ($865.48 million), a 43% increase year-over-year.
&#8220;Our D2C channel has again fueled our growth, increasing by 45.3% year-over-year on a reported basis and 42.4% on a constant currency basis, reaching net sales of CHF 276.9 million($330.13 million),&#8221; said CFO and Co-CEO Martin Hoffmann. &#8220;This growth ahead of our expectations has further resulted in an increased D2C share of 38.1% in the first quarter of 2025, up from 37.5% in the first quarter of 2024.&#8221;
Executive Co-Chairman Caspar Coppetti highlighted, &#8220;The strength of our direct to consumer business and its increased share resulted in an increased gross profit margin of 59.9%.&#8221; 
See Also: <a href="https://www.benzinga.com/markets/25/05/45397196/jensen-huangs-wealth-surges-37-since-liberation-day-lows-as-nvidia-re-enters-3-trillion-market-cap-club-on-saudi-chip-pact">Jensen Huang&#8217;s Wealth Surges 37% Since &#8216;Liberation Day&#8217; Lows As Nvidia Re-Enters $3 Trillion Market Cap Club On Saudi Chip Pact</a>
Why It Matters: Based on strong results, On raised its 2025 outlook, now expecting constant currency growth of at least 28%, with reported sales projected to reach at least CHF 2.8 billion ($3.34 billion). 
The company plans to raise U.S. prices starting in July to reinforce its premium brand positioning and cushion the impact of potential tariffs imposed under President Donald Trump.
Hoffmann concluded, &#8220;We are convinced that our partners and fans will continue to invest into the most premium offering in the market, setting us up for long term success from this position of strength.&#8221;
Price Action: On Holding AG&#8217;s stock closed at $57.38 on Tuesday, rising 11.83% for the day. In after-hours trading, the stock dipped slightly to $57.21, down 0.30%. Year to date, On Holding has gained 3.63%.
Photo Courtesy: Ricardo Trida On Shutterstock.com
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45397119/etoro-set-for-nasdaq-debut-crypto-and-stock-trading-platform-announces-upsized-ipo-priced-at-52-per-share">eToro Set For Nasdaq Debut, Crypto And Stock Trading Platform Announces Upsized IPO Priced At $52 Per Share</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments

Synergy CHC

ニュース

最新ニュース Synergy CHC (NASDAQ:SNYR) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル